EKO International Corp. (EKNL) Stock
Headquartered in Burlington, Canada, EKO International Corp. operates via its joint venture with NeuroVasc Clinical Inc.
Valuation
Financials & Margins
Annual Financials (USD)
Balance Sheet (USD)
Cash Flow (USD)
Valuation & Return Ratios
Peer Comparison
About EKO International Corp.
Headquartered in Burlington, Canada, EKO International Corp. operates via its joint venture with NeuroVasc Clinical Inc. This partnership is responsible for the marketing and supply of frequency rhythmic electrical modulation system (FREMS) equipment throughout Canada, used in addressing peripheral neuropathy. Moreover, through the same joint venture, the company is involved in establishing and managing clinical facilities that provide patient care utilizing FREMS technology.
EKO International Corp. (EKNL) stock trades at $0.00 with a market capitalization of $6337. The stock is valued at a price-to-earnings (P/E) ratio of 0.00, price-to-book of 0.00, price-to-sales of 0.00. Over the past 52 weeks the stock has ranged between $0.00 and $0.00, and currently trades —% below its 52-week high.
On profitability, EKO International Corp. generates a return on equity (ROE) of 33.33% — well above the market average, a sign of a high-quality business, return on capital employed of 26.75%, an operating margin of 0.00%, a net profit margin of 0.00%.
Official website: www.ekointl.com